Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 1197 of 2843 -
Monday, February 09 2026 | 05:55:34 PM

Sonim Technologies Confirms Receipt of Unsolicited, Non-Binding Proposal from Orbic North America, LLC

No stockholder action required at this time San Diego, California–(Newsfile Corp. – June 27, 2025) – The Special Committee of the Board of Directors (the “Special Committee”) of Sonim Technologies, Inc. (NASDAQ: SONM), formed to oversee the Company’s ongoing strategic alternatives process, today confirmed receipt of an unsolicited, non-binding proposal …

Read More »

GGBET UA Became the Title Sponsor of FC Dynamo Kyiv

The partnership was announced on 25 June at the Dynamo 3.0 media event held in Kyiv, Ukraine. GG.BET is the first betting brand in the club’s history to be given title sponsor status. Kyiv, Ukraine–(Newsfile Corp. – June 27, 2025) – Kyiv was the venue of a press conference with …

Read More »

Announcing the Winners of the 2025 Bulldog PR Awards

Ridgefield Park, New Jersey–(Newsfile Corp. – June 27, 2025) – Bulldog Reporter is thrilled to announce the winners of the 2025 Bulldog PR Awards, recognizing outstanding achievements in the PR and communications industry over the past year. Renowned as the only PR awards program judged exclusively by journalists, the Bulldog …

Read More »

Sona Announces Ethics Committee Approval For Melanoma Clinical Trial

Halifax, Nova Scotia–(Newsfile Corp. – June 27, 2025) – Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the “Company“, “Sona“), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod technology, announces that it has received ethics committee approval to proceed with its previously announced early …

Read More »

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Vancouver, British Columbia–(Newsfile Corp. – June 27, 2025) – InMed Pharmaceuticals Inc. (NASDAQ: INM) (“InMed” or the “Company“), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today announced the closing of its previously announced private placement priced at-the-market under …

Read More »

New Inversion Data Reveals Six Anomalies at Aurania’s Awacha Target

Toronto, Ontario–(Newsfile Corp. – June 27, 2025) – Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) (FSE: 20Q) (“Aurania” or the “Company”) reports that reprocessing Mobile MagnetoTellurics (MobileMT) data from the Company’s Awacha porphyry copper target in Ecuador using the latest 2D inversion technology has revealed six highly conductive anomalies. In …

Read More »